Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Pancreatic Adenocarcinoma”

282 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 282 results

Testing effectiveness (Phase 2)Study completedNCT00003760
What this trial is testing

Irofulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
The University of Texas Health Science Center at San Antonio 3
Testing effectiveness (Phase 2)WithdrawnNCT00253526
What this trial is testing

Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage I Pancreatic Cancer+2 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00101348
What this trial is testing

Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more
National Cancer Institute (NCI) 66
Not applicableEnrolling By InvitationNCT07241676
What this trial is testing

Early Recurrence After Surgery for Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Recurrent Pancreatic Adenocarcinoma
Azienda Ospedaliera di Padova 500
Not applicableStudy completedNCT00900016
What this trial is testing

Studying Fibroblast Activity in Patients With Localized Pancreatic Cancer Undergoing Surgery

Who this might be right for
Pancreatic Cancer
Fox Chase Cancer Center 37
Early research (Phase 1)Active Not RecruitingNCT02495896
What this trial is testing

Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaMetastatic Pancreatic AdenocarcinomaNon-Resectable Cholangiocarcinoma+13 more
University of Southern California 61
Early research (Phase 1)Study completedNCT00066651
What this trial is testing

Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors

Who this might be right for
Cervical CancerFallopian Tube CancerHead and Neck Cancer+5 more
National Cancer Institute (NCI)
Not applicableStudy completedNCT01129167
What this trial is testing

Frequency of Methods of Local Invasion of Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
Columbia University 1,052
Testing effectiveness (Phase 2)Study completedNCT00962312
What this trial is testing

Lapatinib Ditosylate and Capecitabine in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Cancer Trials Ireland 9
Testing effectiveness (Phase 2)Study completedNCT00095966
What this trial is testing

Sorafenib and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage II Pancreatic Cancer+2 more
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Study completedNCT00499486
What this trial is testing

Sirolimus in Treating Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 47
Testing effectiveness (Phase 2)Study completedNCT01806675
What this trial is testing

18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+41 more
Sanjiv Sam Gambhir 25
Testing effectiveness (Phase 2)Study completedNCT00004895
What this trial is testing

Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery

Who this might be right for
Colorectal CancerConstipation, Impaction, and Bowel ObstructionExtrahepatic Bile Duct Cancer+7 more
Northwestern University
Testing effectiveness (Phase 2)Study completedNCT01781728
What this trial is testing

Palliative Stereotactic Radiation for Pancreatic or Periampullary Adenocarcinoma

Who this might be right for
Pancreatic CancerPeriampullary Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 48
Testing effectiveness (Phase 2)UnknownNCT00275119
What this trial is testing

Gemcitabine and Oxaliplatin Followed By Radiation Therapy, Fluorouracil, and Oxaliplatin in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery

Who this might be right for
Pancreatic Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Testing effectiveness (Phase 2)Looking for participantsNCT06051695
What this trial is testing

Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Who this might be right for
Solid Tumor, AdultColorectal CancerNSCLC+17 more
A2 Biotherapeutics Inc. 474
Early research (Phase 1)Active Not RecruitingNCT01660971
What this trial is testing

Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Metastatic Pancreatic AdenocarcinomaRecurrent Pancreatic CarcinomaStage III Pancreatic Cancer AJCC v6 and v7+1 more
National Cancer Institute (NCI) 19
Not applicableUnknownNCT04605237
What this trial is testing

Pancreatic Cancer Recurrence in the Netherlands

Who this might be right for
Pancreatic Ductal AdenocarcinomaPancreatic CancerPancreas Cancer+1 more
UMC Utrecht 1,750
Testing effectiveness (Phase 2)Active Not RecruitingNCT05915351
What this trial is testing

Enfortumab Vedotin in Previously Treated Locally Advanced or Metastatic Pancreatic Cancer (EPIC)

Who this might be right for
Pancreatic Ductal AdenocarcinomaPancreas AdenocarcinomaPancreas Cancer
University of Kansas Medical Center 28
Testing effectiveness (Phase 2)Study completedNCT02907099
What this trial is testing

Pembrolizumab and CXCR4 Antagonist BL-8040 in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic AdenocarcinomaRecurrent Pancreatic AdenocarcinomaStage IV Pancreatic Cancer AJCC v6 and v7
M.D. Anderson Cancer Center 20
Load More Results